解码免疫反应:分析缺血性中风中的PBMC和评估里瓦洛克萨班对基因表达的影响
Talar Ahmad Merza Mohammad1, Maysoon Al-Haideri2, Abdulqader Azeez Al-Naqshabandi3
1College of pharmacy Hawler Medical University Kurdistan region Iraq; University of Kurdistan Hewlêr (UKH) School of Medicine/ pharmacy department Kurdistan Region-Erbil Iraq.
Human immunology
|February 4, 2025
概括
里瓦洛克萨班可以通过降低CXCL8,CXCL2和G0S2.2等关键基因的调节来减少缺血性中风 (IS) 的炎症. 这为针对性治疗提供了潜在的潜力,以对抗中风相关的炎症.
科学领域:
- 心血管研究研究心血管研究
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 缺血性中风 (IS) 是导致死亡和残疾的主要原因,由复杂的炎症过程驱动.
- 心房的患者使用Rivaroxaban,XA因子抑制剂,用于预防中风.
- 了解IS中的基因表达和里瓦洛克萨班的作用至关重要.
研究的目的:
- 在缺血性中风 (IS) 患者中识别失调基因.
- 研究里瓦罗克萨班治疗对IS特定基因和蛋白质表达的影响.
- 探索里瓦罗克萨班在IS中的潜在抗炎机制.
主要方法:
- 利用来自GEO数据库的基因表达数据进行IS患者分析.
- 使用RT-PCR和ELISA测量了IS患者在Rivaroxaban治疗前和后的CXCL8,CXCL2和G0S2表达.
- 使用Enrichr在线工具进行功能丰富分析.
主要成果:
- 与对照组相比,GEO2R分析在IS样本中发现了CXCL8,CXCL2和G0S2的显著上调.
- 里瓦洛克萨班治疗导致这些基因的mRNA和蛋白质水平显著降低.
- 这些发现表明,里瓦罗克萨班在IS中具有潜在的抗炎作用.
结论:
- 里瓦罗克萨班可以调节缺血性中风 (IS) 患者的炎症反应.
- 已确定CXCL8,CXCL2和G0S2是涉及IS的关键基因.
- 结果突出了针对性治疗策略的潜力,以减轻中风引起的炎症.
更多相关视频
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...